Skyhawk Therapeutics H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Waltham, MA HQ🌐 skyhawktx.com
Does Skyhawk Therapeutics sponsor H-1B visas and green cards?
Yes. Skyhawk Therapeutics has filed 12 H-1B LCAs and 3 PERM green-card cases with the U.S. Department of Labor between FY2019 and FY2026. In FY2022 Skyhawk Therapeutics filed 4 H-1B LCAs at a median base salary of $116,500, about 7% above the national H-1B median of $108,653 for the same period. 2 green-card cases were decided in FY2022.
Waltham, MA accounts for 100% of its H-1B filings.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2022 | 4 | $117k |
| FY2021 | 2 | $118k |
| FY2020 | 3 | $105k |
| FY2019 | 3 | $87k |
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2022 | 2 | $149k |
| FY2021 | 1 | $226k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 13
- US patents
- Published, not yet granted
- 36
- applications
- Most recent grant
- January 13, 2026
- Top area
- Heterocyclic compounds10
About Skyhawk Therapeutics
- Name (DOL filings)
- Skyhawk Therapeutics, Inc.
- Listed
- —
- Sponsoring since
- FY2019
- Main filing location
- Waltham, MA
- Industry
- Pharma & biotech
- Website
- skyhawktx.com
- H-1B filings
- 12
- Median base
- $101,500
- R&D
- —
H-1B sponsors similar to Skyhawk Therapeutics
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Abon Pharmaceuticals | 13 | 1 | $97k | 0 | — |
| Ascentage Pharma Group | 13 | 2 | $119k | 0 | — |
| Arvinas Operations | 13 | 5 | $136k | 1 | — |
| Skyhawk Therapeutics | 12 | 0 | — | 0 | — |
| Chemgenes | 12 | 1 | $100k | 0 | — |
| Amicus Therapeutics | 12 | 1 | $103k | 0 | — |
| AmplifyBio | 12 | 4 | $128k | 1 | — |
